LB-100
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for LB-100, covering 2017-01-24 to 2026-04-07. Get the full timeline:
Most recent: Clinical Trial Update: LB-100, Carboplatin, Etoposide, and Atezolizumab for the Treatment of Untreated Extensive-Stage Small Cell Lung Cancer [Phase 1]